Oral carnitine supplementation for dyslipidemia in chronic hemodialysis patients
Carnitine deficiency is a commonly observed problem in maintenance hemodialysis (MHD) patients, which results in altered metabolism of fatty acids and subsequently development of dyslipidemia. To evaluate the effect of oral L-carnitine (LC) supplementation on lipid profile of adult MHD patients, we...
Main Authors: | Afsoon Emami Naini, Masoumeh Sadeghi, Mojgan Mortazavi, Mojdeh Moghadasi, Asghar Amini Harandi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2012-01-01
|
Series: | Saudi Journal of Kidney Diseases and Transplantation |
Online Access: | http://www.sjkdt.org/article.asp?issn=1319-2442;year=2012;volume=23;issue=3;spage=484;epage=488;aulast=Naini |
Similar Items
-
Effects of Carnitine Supplement on Dyslipidemia and Anemia in Hemodialysis Patients
by: Afsoon Emami Naini, et al.
Published: (2011-07-01) -
The Prevalence of Metabolic Syndrome in Patients on Hemodialysis and Peritoneal Dialysis: A Comparative Study
by: Mojgan Mortazavi, et al.
Published: (2012-03-01) -
The Effect of Oral L-carnitine on Serum Albumin and Inflammatory Markers Levels in Patients under Peritoneal Dialysis: A Randomized Controlled Trial
by: Mojgan Mortazavi, et al.
Published: (2011-07-01) -
The role of oral L-Carnitine therapy in chronic hemodialysis patients
by: Sabry Alaa
Published: (2010-01-01) -
The effect of omega-3 fatty acid supplementation on oxidative stress in continuous ambulatory peritoneal dialysis patients
by: Shahram Taheri, et al.
Published: (2014-01-01)